malaria pharmacology Flashcards
most common strains of malaria
P.falciparum ~75%
P.vivax/ovale
p.falciparum characteristics
- most common cause of mortality
- symptoms appear after 5-15 days after RBC lysis
p.vivax/ovale characteristics
- look very similar
- exoerythrocytic (liver) stage lasts for long
infection sequence of malaria
- female mosquito deposits spores
- spores collect in liver where they multiply for days to weeks
- spores enter RBCs, multiply
- RBCs lyse and spread more spores
symptoms of malaria
- anemia
- fever
- chills
- nausea
- flu-like symptoms
- hypoglycemia
- seizures
- multiple organ failure
stages of infection
- exoerythrocytic stage (liver)
- erythrocytic stage (RBC)
- latent (only P.vivax/ovale)
drug for exoerythrocytic stage
palurdrine (proguanil)
drug for latent exoerythrocytic
primaquine
rapid acting drugs for erythrocytic stage
chloroquine
quinine
mefloquine
artemisinin
slow acting drugs for erythrocytic stage
pyrimethamine
tetracyclines
sulfonamides
combo therapy drug
atovaquone/proguanil
proguanil MOA
inhibit plasmodial dihydrofolate reductase, inhibiting DNA synthesis
proguanil use
prophylaxis primarily, sometimes treatment
proguanil adverse effects
diarrhea
nausea
primaquine use
hepatic and latent p.vivax/ovule
primaquine adverse effects
mild GI
methemoglobinemia
primaquine contraindications
glucose-6-phosphate deficiency
chloroquine MoA
prevents parasite from inactivating heme
why isn’t chloroquine used much
resistance in p.falciparum is common enough
chloroquine adverse effects
- GI disturbances
- blurred vision
- possibly hypotension and cardiac arrest
chloroquine contraindications
psoriasis or porphyria, can cause flares
quinine MoA
interference with heme metabolism
quinine use
- treatment of choice for chloroquine resistant strains of p.falciparum
- NO Prophylaxis
quinine adverse effects
GI
vision
hypoglycemia
mefloquine MoA
unknown, maybe similar to chloroquine